{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2021-05-27&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-20T16%3A45%3A48.73Z&tablingMemberConstituency=Newcastle+upon+Tyne+Central&max-answer.dateOfAnswer=2022-07-19", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-date=2021-05-27&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-20T16%3A45%3A48.73Z&tablingMemberConstituency=Newcastle+upon+Tyne+Central&max-answer.dateOfAnswer=2022-07-19", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2021-05-27&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-20T16%3A45%3A48.73Z&tablingMemberConstituency=Newcastle+upon+Tyne+Central&_metadata=all&max-answer.dateOfAnswer=2022-07-19", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-date=2021-05-27&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-20T16%3A45%3A48.73Z&tablingMemberConstituency=Newcastle+upon+Tyne+Central&max-answer.dateOfAnswer=2022-07-19", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2021-05-27&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-20T16%3A45%3A48.73Z&tablingMemberConstituency=Newcastle+upon+Tyne+Central&max-answer.dateOfAnswer=2022-07-19", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2021-05-27&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-20T16%3A45%3A48.73Z&tablingMemberConstituency=Newcastle+upon+Tyne+Central&max-answer.dateOfAnswer=2022-07-19", "items" : [{"_about" : "http://data.parliament.uk/resources/1490463", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1490463/answer", "answerText" : {"_value" : "<p>Last year over 1 million people accessed talking therapies services in the community. We delivered waiting-time promises for adult talking therapies, with 88.8% of people accessing treatment within 6 weeks, and 98.4% within 18 weeks. In April 2022, patients were waiting on average 22.8 days from the point of referral to starting adult talking therapies, nationally.<\/p><p>For children and young people, we are working towards our aim for 95% accessing eating disorder services within 1 week for urgent cases and 4 weeks for routine cases.<\/p><p>This year NHS England published consultation outcomes on five new access and waiting time standards for mental health services. We are currently working with NHS England on next steps for implementation.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4680", "label" : {"_value" : "Biography information for Gillian Keegan"}
        }
        , "answeringMemberConstituency" : {"_value" : "Chichester"}
        , "answeringMemberPrinted" : {"_value" : "Gillian Keegan"}
        , "dateOfAnswer" : {"_value" : "2022-07-19", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-07-19T15:54:28.45Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-07-19", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Mental Health Services: Waiting Lists"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the average waiting time for mental health treatment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "901168"}
    , {"_about" : "http://data.parliament.uk/resources/1489336", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1489336/answer", "answerText" : {"_value" : "<p>The National Institute for Health and Care Excellence (NICE) makes recommendations on whether new cancer medicines should be routinely funded by the National Health Service through its technology appraisal programme. NICE has published final technology appraisal guidance on three cancer medicines which have received marketing authorisation from the Medicines and Healthcare products Regulatory Agency through Project Orbis. NICE has also, published final draft guidance on sacituzumab govitecan for treating unresectable locally advanced or metastatic triple-negative breast cancer after two or more therapies, which is now available to NHS patients through the Cancer Drugs Fund.<\/p><p>The Department holds regular accountability meetings with NICE to discuss a range of issues, such as staffing and resource capacity issues which may impact on NICE\u2019s ability to deliver on its commitments. In 2022/23, NICE plan to increase the flexibility and capacity of its technology appraisal programme through a more proportionate approach to assessments. From April 2023, NICE aims to expand its capacity for technology appraisals by 20%, to enable it to respond to the increasing numbers of topics referred for appraisal in a timely manner.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
        }
        , "answeringMemberConstituency" : {"_value" : "Lewes"}
        , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
        , "dateOfAnswer" : {"_value" : "2022-07-19", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-07-19T16:34:39.11Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-07-14", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cancer: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many medicines approved by the Medicines and Healthcare products Regulatory Agency under Project Orbis have received a decision on reimbursement by the National Institute for Health and Care Excellence (NICE); and what recent assessment he has made of the adequacy of NICE\u2019s staffing and resourcing capacity.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "36759"}
    , {"_about" : "http://data.parliament.uk/resources/1489340", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1489340/answer", "answerText" : {"_value" : "<p>Financial support is provided by the Department for Education. In the academic year 2022/23, the Department for Education has approved funding for 15 Access to Higher Education Diplomas in Nursing through the Adult Education Budget or Advanced Learner Loans. If a learner then completes an eligible higher education course, the balance of the Advanced Learner Loan for the Access course will be written off.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
        }
        , "answeringMemberConstituency" : {"_value" : "Lewes"}
        , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
        , "dateOfAnswer" : {"_value" : "2022-07-19", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-07-19T16:25:43.95Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-07-14", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Nurses: Training"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department provides support for people seeking to enrol in an access course to train at university as a nurse.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "36761"}
    , {"_about" : "http://data.parliament.uk/resources/1484887", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1484887/answer", "answerText" : {"_value" : "<p>We have no plans to make such an assessment. National Health Service regional teams are responsible for assessing local capacity and commissioning the appropriate NHS dental services. The Department works with NHS England to monitor the delivery of commissioned levels of care in England.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3992", "label" : {"_value" : "Biography information for James Morris"}
        }
        , "answeringMemberConstituency" : {"_value" : "Halesowen and Rowley Regis"}
        , "answeringMemberPrinted" : {"_value" : "James Morris"}
        , "dateOfAnswer" : {"_value" : "2022-07-19", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-07-19T09:28:27.9Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-06-29", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Dental Services: Newcastle Upon Tyne"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 June 2022 to Question 13119 on Dental Services: North East, if he will make an assessment of whether dentists at NHS Newcastle Gateshead Clinical Commissioning Group have capacity to take on additional patients as on 29 June 2022; and if he will make an estimate of the number of dentists per capita there were in the NHS Newcastle Gateshead Clinical Commissioning Group in the 2010-11 financial year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "27600"}
    , {"_about" : "http://data.parliament.uk/resources/1484170", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1484170/answer", "answerText" : {"_value" : "<p>Formal complaints procedures are conducted at individual National Health Service trust and provider level. Through the NHS People Plan, NHS England and NHS Improvement have launched a training programme for Freedom to Speak Up Guardians to improve understanding of inequality experienced by ethnic minority staff and to seek their views.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2022-07-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "25851"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-07-04T14:25:19.837Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-06-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Health Services: Racial Discrimination"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to improve the complaints procedure for incidents of workplace racism in medical settings, as recommended in the British Medical Association\u2019s report entitled Delivering racial equality in medicine, published in June 2022.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "26763"}
    , {"_about" : "http://data.parliament.uk/resources/1483631", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1483631/answer", "answerText" : {"_value" : "<p>The National Health Service Civility and Respect programme aims to tackle discrimination, bullying and harassment in the NHS and to create positive workplace cultures.<\/p><p>The NHS is improving recruitment processes and career opportunities for all staff, including medical professionals, from ethnic minority backgrounds. The Medical Workforce Racial Equality Standard report in 2020 showed that the number of black and minority ethnic doctors increased by 21.1% compared to 2017. We have accepted the recommendations from the \u2018Leadership for a collaborative and inclusive future\u2019 review into health and social care leadership in full. The recommendations include embedding inclusive leadership practice as the responsibility of all and promoting equal opportunity and fairness standards to tackle discrimination.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2022-06-30", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-30T12:43:12.607Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-06-27", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Health Professions: Racial Discrimination"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the British Medical Association\u2019s report entitled, Delivering racial equality in medicine, what steps he is taking to (a) protect and support medical professionals from racist abuse and (b) help ensure Black and Ethnic Minority groups are not dissuaded from pursuing medical careers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "25850"}
    , {"_about" : "http://data.parliament.uk/resources/1483633", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1483633/answer", "answerText" : {"_value" : "<p>Formal complaints procedures are conducted at individual National Health Service trust and provider level. Through the NHS People Plan, NHS England and NHS Improvement have launched a training programme for Freedom to Speak Up Guardians to improve understanding of inequality experienced by ethnic minority staff and to seek their views.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2022-07-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "26763"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-07-04T14:25:19.793Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-06-27", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Health Professions: Racial Discrimination"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the recommendation in the British Medical Association\u2019s report entitled, Delivering Racial Equality in Medicine, what steps his Department is taking to help improve the complaints procedure for incidents of workplace racism in medical settings.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "25851"}
    , {"_about" : "http://data.parliament.uk/resources/1468907", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1468907/answer", "answerText" : {"_value" : "<p>The National Institute for Health and Care Excellence (NICE) is an independent body responsible for the methods and processes used in the development of its guidance and recommendations. NICE recently concluded a comprehensive review of its methods and processes for health technology evaluation, including consideration of the discount rate and published its updated manual on 31 January. Officials from the Department of Health and Social Care and HM Treasury were engaged throughout the review.<\/p><p>Following a public consultation, NICE concluded that while there was some evidence to support a change to the reference case discount rate, it was appropriate to maintain the existing reference case discount rate of 3.5% due to wider policy and fiscal implications. NICE has retained the flexibility for its committees to apply a lower non-reference case discount rate of 1.5% in exceptional circumstances. This flexibility has previously been applied by NICE when evaluating advanced therapeutic medicinal products, such as its positive appraisal of the gene therapy Zolgensma for the treatment of spinal muscular atrophy.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2022-06-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1468907/answer/previousversion/6254", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
          }
          , "answeringMemberConstituency" : {"_value" : "Charnwood"}
          , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        }
        , "questionFirstAnswered" : [{"_value" : "2022-06-15T09:57:06.343Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-06-09", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Advanced Therapy Medicinal Products"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Chancellor of the Exchequer on the suitability of the current 3.5 percent discount rate applied for assessing cost effectiveness of Advanced Therapy Medicinal Products (ATMP); and what assessment he has made of the potential merits of lowering this rate to better assess the long-term value and transformative effect of ATMPs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "15257"}
    , {"_about" : "http://data.parliament.uk/resources/1468668", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1468668/answer", "answerText" : {"_value" : "<p>There are no current plans to do so. The National Institute for Health and Care Excellence (NICE) recently reviewed and refined the criteria used to make decisions on whether medicines should be routed to its highly specialised technology evaluation programme. The updated criteria are not intended to increase or reduce the number of medicines which are evaluated through the highly specialised technologies programme. NICE has recommended 100% of the Advanced Therapy Medicinal Products it has evaluated through both its technology appraisal and highly specialised technologies programmes which are now routinely available to National Health Service patients.<\/p><p><strong> <\/strong><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
        }
        , "answeringMemberConstituency" : {"_value" : "Lewes"}
        , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
        , "dateOfAnswer" : {"_value" : "2022-06-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-20T10:26:01.083Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-06-08", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Rare Diseases: Advanced Therapy Medicinal Products"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of increasing the use of the NICE Highly Specialised Technologies evaluation process for Advanced Therapy Medicinal Products to treat a wide range of rare and ultra-rare diseases.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "14485"}
    , {"_about" : "http://data.parliament.uk/resources/1468251", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1468251/answer", "answerText" : {"_value" : "<p>Restrictions on the advertising of products high in fat, salt or sugar (HFSS) on television before 9pm and paid for advertising online will be introduced on 1 January 2024. This will supplement existing restrictions on HFSS advertising during children\u2019s and other programming of particular appeal to children.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4447", "label" : {"_value" : "Biography information for Maggie Throup"}
        }
        , "answeringMemberConstituency" : {"_value" : "Erewash"}
        , "answeringMemberPrinted" : {"_value" : "Maggie Throup"}
        , "dateOfAnswer" : {"_value" : "2022-06-21", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-21T16:32:16.657Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-06-07", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Food: Advertising"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to restrict advertising for foods that are high in fat, sugar or salt to help reduce obesity.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"}
      , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"}
      ], "uin" : "13711"}
    ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&min-date=2021-05-27&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-05-20T16%3A45%3A48.73Z&tablingMemberConstituency=Newcastle+upon+Tyne+Central&max-answer.dateOfAnswer=2022-07-19", "page" : 0, "startIndex" : 1, "totalResults" : 98, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}